What happens in early, still undetectable human malignancies is unknown because direct
observations are impractical. Here we present and validate a'Big Bang'model, whereby …

Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We
used the bioinformatics tools 'expanding ploidy and allele frequency on nested …

Despite extraordinary efforts to profile cancer genomes, interpreting the vast amount of
genomic data in the light of cancer evolution remains challenging. Here we demonstrate that …

Tumorigenesis begins long before the growth of a clinically detectable lesion and, indeed,
even before any of the usual morphological correlates of pre-malignancy are recognizable. …

Neoplasms change over time through a process of cell-level evolution, driven by genetic and
epigenetic alterations. However, the ecology of the microenvironment of a neoplastic cell …

Objectives: This study provides an overview of the largest and longest-running colonoscopic
surveillance program for colorectal cancer (CRC) in patients with long-standing ulcerative …

Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary
dynamics that produce tumor subclones remain unknown. Here we measure clone …

Human intestinal stem cell and crypt dynamics remain poorly characterized because transgenic
lineage-tracing methods are impractical in humans. Here, we have circumvented this …

Genetic and epigenetic variation, together with transcriptional plasticity, contribute to
intratumour heterogeneity 1 . The interplay of these biological processes and their respective …

Epithelium of the colon and intestine are renewed every 3 days. In the intestine there are at
least two principal stem cell pools. The first contains rapid cycling crypt-based columnar (CBC…